Steven P. Angus

2.6k total citations
47 papers, 1.4k citations indexed

About

Steven P. Angus is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Steven P. Angus has authored 47 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 19 papers in Oncology and 10 papers in Cell Biology. Recurrent topics in Steven P. Angus's work include Cancer-related Molecular Pathways (14 papers), Microtubule and mitosis dynamics (10 papers) and Protein Degradation and Inhibitors (8 papers). Steven P. Angus is often cited by papers focused on Cancer-related Molecular Pathways (14 papers), Microtubule and mitosis dynamics (10 papers) and Protein Degradation and Inhibitors (8 papers). Steven P. Angus collaborates with scholars based in United States, Germany and United Kingdom. Steven P. Angus's co-authors include Gary L. Johnson, Erik S. Knudsen, Jon S. Zawistowski, Timothy J. Stuhlmiller, Michael Markey, Ranjaka W. Gunawardena, Lee M. Graves, Matthew W. Strobeck, Noah Sciaky and Joseph R. Nevins and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Steven P. Angus

45 papers receiving 1.3k citations

Peers

Steven P. Angus
Bradley L. Smith United States
Jeffrey Skolnik United States
Harold Hatch United States
Mengqian Chen United States
Esra A. Akbay United States
Nagarajan Kannan United States
Bradley L. Smith United States
Steven P. Angus
Citations per year, relative to Steven P. Angus Steven P. Angus (= 1×) peers Bradley L. Smith

Countries citing papers authored by Steven P. Angus

Since Specialization
Citations

This map shows the geographic impact of Steven P. Angus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven P. Angus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven P. Angus more than expected).

Fields of papers citing papers by Steven P. Angus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven P. Angus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven P. Angus. The network helps show where Steven P. Angus may publish in the future.

Co-authorship network of co-authors of Steven P. Angus

This figure shows the co-authorship network connecting the top 25 collaborators of Steven P. Angus. A scholar is included among the top collaborators of Steven P. Angus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven P. Angus. Steven P. Angus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lukkes, Jodi L., M. Sullivan, Nathan Cunningham, et al.. (2025). A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/– mice. Journal of Clinical Investigation. 135(13). 1 indexed citations
2.
Zhou, Zhuan, Chunhui Jiang, Waylan Bessler, et al.. (2025). TGFβ-dependent signaling drives tumor growth and aberrant extracellular matrix dynamics in NF1-associated plexiform neurofibroma. Science Advances. 11(25). eadu0772–eadu0772. 1 indexed citations
3.
Liu, Sheng, Jun Wan, Steven P. Angus, et al.. (2025). PLK1 Inhibition Induces Synthetic Lethality in Fanconi Anemia Pathway–Deficient Acute Myeloid Leukemia. Cancer Research Communications. 5(4). 648–667. 1 indexed citations
4.
Sait, Sameer Farouk, Kwan Ho Tang, Steven P. Angus, et al.. (2024). Hydroxychloroquine prevents resistance and potentiates the antitumor effect of SHP2 inhibition in NF1-associated malignant peripheral nerve sheath tumors. Proceedings of the National Academy of Sciences. 122(1). e2407745121–e2407745121. 2 indexed citations
5.
Stieglitz, Elliot, Alex G. Lee, Steven P. Angus, et al.. (2024). Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children’s Oncology Group. Cancer Discovery. 14(9). 1590–1598. 4 indexed citations
6.
Stieglitz, Elliot, Alex Lee, Steven P. Angus, et al.. (2023). Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: A Report from the Children's Oncology Group. Blood. 142(Supplement 1). 74–74. 2 indexed citations
7.
Mehta, Gaurav, Steven P. Angus, Kevin Tong, et al.. (2021). SOX4 and SMARCA4 cooperatively regulate PI3k signaling through transcriptional activation of TGFBR2. npj Breast Cancer. 7(1). 40–40. 14 indexed citations
8.
Angus, Steven P., Benjamin J. Huang, Chi Zhang, et al.. (2020). Nf1 -Mutant Tumors Undergo Transcriptome and Kinome Remodeling after Inhibition of either mTOR or MEK. Molecular Cancer Therapeutics. 19(11). 2382–2395. 2 indexed citations
9.
Ma, Yun, Andrea M. Gross, Eva Dombi, et al.. (2020). A molecular basis for neurofibroma-associated skeletal manifestations in NF1. Genetics in Medicine. 22(11). 1786–1793. 16 indexed citations
10.
Bevill, Samantha M., Noah Sciaky, Brian T. Golitz, et al.. (2019). GSK2801, a BAZ2/BRD9 Bromodomain Inhibitor, Synergizes with BET Inhibitors to Induce Apoptosis in Triple-Negative Breast Cancer. Molecular Cancer Research. 17(7). 1503–1518. 44 indexed citations
11.
Brighton, Hailey E., Steven P. Angus, Tao Bo, et al.. (2017). New Mechanisms of Resistance to MEK Inhibitors in Melanoma Revealed by Intravital Imaging. Cancer Research. 78(2). 542–557. 57 indexed citations
12.
Shats, Igor, Michael L. Gatza, Beiyu Liu, et al.. (2013). FOXO Transcription Factors Control E2F1 Transcriptional Specificity and Apoptotic Function. Cancer Research. 73(19). 6056–6067. 42 indexed citations
13.
Angus, Steven P., et al.. (2013). MAP3K1: Genomic Alterations in Cancer and Function in Promoting Cell Survival or Apoptosis. Genes & Cancer. 4(11-12). 419–426. 96 indexed citations
14.
Mayhew, Christopher N., Emily E. Bosco, David A. Solomon, Erik S. Knudsen, & Steven P. Angus. (2004). Analysis of RB Action in DNA Damage Checkpoint Response. Humana Press eBooks. 281. 3–16. 7 indexed citations
15.
Gunawardena, Ranjaka W., Hasan Siddiqui, David A. Solomon, et al.. (2004). Hierarchical Requirement of SWI/SNF in Retinoblastoma Tumor Suppressor-mediated Repression of Plk1. Journal of Biological Chemistry. 279(28). 29278–29285. 36 indexed citations
16.
Angus, Steven P., et al.. (2003). Retinoblastoma Tumor Suppressor: Analyses of Dynamic Behavior in Living Cells Reveal Multiple Modes of Regulation. Molecular and Cellular Biology. 23(22). 8172–8188. 31 indexed citations
17.
Angus, Steven P., Anne F. Fribourg, Michael Markey, et al.. (2002). Active RB Elicits Late G1/S Inhibition. Experimental Cell Research. 276(2). 201–213. 31 indexed citations
18.
Strobeck, Matthew W., David Reisman, Ranjaka W. Gunawardena, et al.. (2002). Compensation of BRG-1 Function by Brm. Journal of Biological Chemistry. 277(7). 4782–4789. 100 indexed citations
19.
Angus, Steven P., Linda J. Wheeler, Xiaoping Zhang, et al.. (2002). Retinoblastoma Tumor Suppressor Targets dNTP Metabolism to Regulate DNA Replication. Journal of Biological Chemistry. 277(46). 44376–44384. 75 indexed citations
20.
Xu, Wenjie, et al.. (1999). The Dynein Heavy Chain Gene Family In Tetrahymena Thermophila. Journal of Eukaryotic Microbiology. 46(6). 606–611. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026